Antares Pharma, Inc. (ATRS)

[H2R]

https://seekingalpha.com/article/4112331-antares-pharma-will-october-deliver-triple-play

In view of the foregoing, it is fair to assume that an AB-rated version of the epinephrine injection, marketed by a well-known generic supplier like Teva, will be welcomed by prescribing doctors. In addition, due to a high level of public outrage with Mylan, it is fair to assume that consumers will react very favorably to a new, therapeutically equivalent, EpiPen alternative that can be substituted in prescriptions.